To assess the concentration of free intracellular adenosine in the heart the kinetic properties of cytosolic S-adenosylhomocysteine (SAH) hydrolase were utilized at elevated levels of Lhomocysteine (adenosine+ L-homocysteine^SAH+ H 2 O). Global hypoxia was induced in the isolated perfused guinea pig heart by graded reduction of perfusion medium Po 2 in the presence of saturating concentrations of homocysteine ( A denosine, a potent coronary vasodilator, has been proposed to be involved in the metabolic control of coronary circulation by adjusting coronary blood flow to myocardial oxygen demand.
A denosine, a potent coronary vasodilator, has been proposed to be involved in the metabolic control of coronary circulation by adjusting coronary blood flow to myocardial oxygen demand. 1 -2 In addition to its vasodilatory effect, adenosine antagonizes the inotropic actions of catecholamines 3 -4 and exhibits strong negative chronotropic effects. 5 Both the negative chronotropic and the antiadrenergic effects of adenosine act to reduce oxygen demand of the heart. However, the major question-to what extent endogenously formed adenosine mediates changes in coronary blood flow and attenuates sympathetic stimulation of the heart-has not been finally resolved.
Assessment of the physiological role of adenosine is hindered by imprecise knowledge of the interstitial concentration of adenosine, to which vascular smooth muscle cells and cardiomyocytes are exposed. Different approaches have been used in previous studies to estimate interstitial adenosine concentration, including measurements of adenosine in pericardial superfusate, 6 -7 epicardial well fluid, 8 blood plasma, 9 and cardiac lymph. 10 However, because the metabolism of adenosine is rapid, questions remain about whether adenosine measured in any of these fluid compartments accurately reflects the adenosine concentration in the interstitial space." The major site of adenosine production in the heart is most likely intracellular.
12 - 14 The intracellular adenosine is then released into the interstitial space according to its concentration gradient. Although highly desirable, there is presently
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no analytical technique available to measure the free intracellular adenosine concentration. The bulk of the adenosine assayed in acid tissue extracts is bound to intracellular proteins, most notably to 5-adenosylhomocysteine (SAH) hydrolase. 1516 Hence, small changes in the free adenosine concentration may be missed by measurements based on conventional tissue extraction procedures.
The present study reports a new approach to estimate the free intracellular adenosine concentration that makes use of the kinetic properties of SAH-hydrolase. This enzyme is exclusively associated with the cytosolic compartment, 1217 and catalyzes the reaction SAH + H 2 O^±adenosine + Lhomocysteine. Under control conditions, the net reaction is in the direction of hydrolysis because the reaction products, adenosine and homocysteine, are both rapidly metabolized and are present only at very low concentrations. 18 Since the equilibrium constant of SAH-hydrolase, however, favors synthesis, 19 formation of SAH prevails in the presence of increased levels of homocysteine. Enzyme kinetics predict that with saturating concentrations of L-homocysteine, the rate of SAH formation is directly proportional to the free intracellular adenosine concentration. Since SAH is not further metabolized 20 nor does it permeate cell membranes, 21 the rate of SAH accumulation in cardiac tissue should depend on the free intracellular adenosine concentration.
The goal of the present study was to determine if changes in the free cytosolic adenosine concentration in cardiac tissue can be estimated by measurement of the rate of SAH accumulation. For this purpose, it was necessary to provide evidence that under in vivo conditions 1) SAH-hydrolase can be saturated with L-homocysteine without altering cardiac hemodynamics and 2) the relation between tissue adenosine and SAH accumulation rate is constant over time.
Materials and Methods

Animal Experiments
Hearts from guinea pigs (n = 92) with a body mass of 250-350 g were perfused according to the Langendorff technique with a modified Krebs-Henseleit medium containing (mM): NaCl 116, KCI 4. Thirty minutes after onset of coronary perfusion, when coronary flow had decreased to 4-6 mi/min, L-homocysteine thiolactone was intracoronarily infused at a final concentration of 1.0 mM. To stimulate the endogenous formation of adenosine, in certain experiments hypoxic perfusion was initiated 10 minutes prior to homocysteine infusion by switching to a medium equilibrated with a gas mixture containing 70%, 55%, 30%, and 23% O 2 (5% CO 2 , balance N^). The PO2 of the arterial, as well as of the venous, coronary perfusate was measured using a blood gas analyzer (BMS 2, MK2, blood micro system, Radiometer, Copenhagen).
For measurement of adenosine release from the hearts, coronary effluent perfusate was collected for 0.5-2 minutes. Samples were stored at -20° C until analysis. Under control conditions and at 5, 10, 20, or 30 minutes of homocysteine infusion, hearts were freeze clamped using a large aluminum tong precooled to the temperature of liquid nitrogen. Myocardial tissue samples were freeze dried (Lyovac GT 2, Leybold-Heraeus, Koln, FRG) and stored desiccated until analysis of adenosine and SAH.
The maximal rate of SAH accumulation was determined during infusion of adenosine at a concentration of 100 ixM in the presence of 1 mM homocysteine under normoxic (95% O^ and hypoxic (30% OJ conditions. In these experiments, isolated hearts were perfused at a constant flow of 10 ml/min, coronary perfusion pressure was measured with a pressure transducer (P 23 ID, Statham), and hearts were paced at a constant rate of 300 beats/min. Degradation of adenosine was prevented by simultaneous infusion of erythro-9-(2-hydroxynon-3-yl) adenine (EHNA) at a concentration of 5 /xM. Experiments were terminated after 10 minutes by freeze clamping the hearts during adenosine infusion.
The effect of homocysteine on the vasoreactivity toward adenosine was studied in experiments in which cumulative dose-response curves for infused adenosine (10~8-5xl0~6 M) on coronary conductance were determined. EHNA concentration was 5 /AM and homocysteine was either absent or present at concentrations of 0.2 or 1.0 mM. Substances were infused into the perfusion cannula about 2 cm above the orifice of the coronary arteries at a rate not exceeding 200 ^l/min.
Analytical Procedures
From the freeze-dried samples, connective tissue including atria was removed. To determine tissue levels of adenosine and SAH, samples were homogenized (Ultraturrax, Janke & Kunkel, Staufen, FRG) in ice-cold 0.5 M perchloric acid (10 ml/1 g tissue wt), and after spinning the extracts at 22,OOOg for 20 minutes, the supernatant was neutralized with KOH (1 M), freeze dried, and redissolved in 500-1,500 /nl of distilled water, of which 50-200 /AI were utilized for high-performance liquid chromatography (adenosine and SAH). In addition, 100 p\ of the extract were used for enzymatic analysis of tissue lactate (Monotest Lactat, Boehringer, Mannheim, FRG).
Coronary effluent perfusate was freeze dried, redissolved in 3 ml of 30% methanol/water (vol/vol), and centrifuged for 10 minutes at 6,000g (Minifuge GL, Heraeus, Osterode, FRG). The supernatant was evaporated to dryness (Vortex Evaporator, Buchler, Fort Lee, New Jersey), and the residue was redissolved in 200 n\ of distilled water, of which 50-180 fi\ were assayed for adenosine and inosine by a highperformance liquid chromatography system (Trimodule System, Waters, Eschborn, FRG).
Two pumps were programed for gradient elution of samples injected directly onto a reversed phase column (8-C-18, 5 fim, Waters). A concave gradient was used at a flow rate of 1.5 ml/min over 8 minutes (effluent samples) or 12 minutes (myocardial samples). Initial conditions were 100% solvent A (ammonium acetate, 0.026 M, pH 5), final conditions were 100% solvent B (70/30 methanol/water [vol/vol]). Absorbance of column eluate was measured at A = 254 nm and continuously recorded. Compounds were quantified by measuring peak height and comparing it to standards. Peaks were identified by comparison with retention times of external standards. In a number of samples, adenosine was additionally identified by peak shift. 22 
Calculations and Statistics
To estimate the A" m value of SAH-hydrolase for adenosine under in vivo conditions, SAH accumulation rate was related to an estimate of free intracellular adenosine concentration. Since SAHhydrolase only interacts with free intracellular adenosine, 23 -24 measured global tissue adenosine levels were corrected for the protein-bound and the extracellular fractions. Protein-bound adenosine was assumed to be equivalent to the fraction of adenosine that is not deaminated by treatment with adenosine deaminase and that approximates 90% of total tissue adenosine under control conditions, 23 that is, 1.8 of 2.0 nmoles/g under our experimental conditions. The amount of protein bound adenosine is fairly constant. 25 -26 Hence, differences between measured tissue adenosine and protein bound adenosine (1.8 nmoles/g) were taken to represent the biologically active free adenosine in the entire heart.
From this global level of free adenosine, a global adenosine concentration (AR-ror) is derived after correcting for the water content (0.8 ml/g wet wt) of cardiac muscle. 27 ARJOT is the average of free cellular (ARCELL). interstitial (ARIN-TER), and intravascular (AR VA sc) adenosine concentration, the relative tissue volume representation of these spaces being 0.7/0.2/0.1. 28 Total tissue as well as intravascular adenosine concentrations were determined in the present study. Hence, the intracellular adenosine Data are given as mean±SEM. To compare control values with those obtained during the different interventions, Student's t test for either paired or unpaired data was used. Differences were considered to be significant when p<0.05. In addition, regression analyses were performed based on the individual determinations.
Chemicals
Adenosine, SAH, and adenosine deaminase were obtained from Boehringer, Mannheim, FRG. LHomocysteine thiolactone was purchased from Sigma, Miinchen, FRG. Erythro-9-(2-hydroxynon-3-yl)adenine (EHNA) was obtained from Borroughs Wellcome, Research Triangle Park, North Carolina. All other reagents were obtained from Merck, Darmstadt, FRG.
Results
During normoxic perfusion (95% O 2 -5% CO 2 , Pc»2 = 660±15 mm Hg) tissue levels of adenosine and SAH were 2.1 ±0.2 and 1.1 ±0.2 nmoles/g (n = 6), respectively. Under these conditions, hearts released adenosine and inosine at rates of 66 ±9 and 285 ± 34 pmoles/min (n = 4), respectively. Intracoronary infusion of homocysteine at a concentration of 1 mM slightly decreased adenosine and inosine release. After 1 minute, respective values were 51 ±8 (NS) and 192±34 (p<0.05) pmoles/min, and after 10 minutes, 50±9 (NS) and 171 ±32 (p<0.05) pmoles/min (n = 4). This reduction in cardiac nucleoside release was paralleled by the following changes in myocardial adenosine and SAH levels. During homocysteine infusion, tissue levels of adenosine remained unaltered in the normoxic heart (2.0 ±0.2 vs. 2.1 ±0.2 nmoles/g) while myocardial levels of SAH continuously increased at a rate of 0.22 nmoles/ g/min. This rise was statistically significant (p<0.0\, n = 18; Figure 1 ).
Homocysteine at the given concentration (1 mM) did not alter cardiac performance of the normoxic heart but slightly increased coronary flow (Table 1) . However, homocysteine did not influence the vasoactivity of intracoronarily infused adenosine. EC50 values for coronary vasodilation measured in the absence as well as in the presence of 0.2 and 1.0 mM homocysteine were identical (1.2xlO~7M;n = 6). During hypoxic perfusion (30% 0 2 , 5% CO 2 , 65% N 2 ; Po 2 = 230± 10 mm Hg) tissue levels of adenosine and SAH were 3.5 ±0.2 and 1.2±0.3 nmoles/g, respectively, while release of adenosine and inosine was markedly enhanced to 1,215 ±232 and 6,743 ±753 pmoles/min, respectively (n = 4). Homocysteine (1 mM) decreased cardiac adenosine and inosine release to 609± 175 and 3,088±423 pmoles/ min (n = 4) after 1 minute, and to 464±155 and 1,517 ±606 pmoles/min after 10 minutes, respectively (n = 4). As shown in Figure 1 , tissue adenosine initially decreased from 3.5±0.2 to a new steady-state level of 2.8 ±0.2 nmoles/g, while SAH levels increased linearly at a rate of 2.5 nmoles/ g/min (p<0.01, n = 16). Homocysteine did not significantly alter the hypoxia-induced changes of myocardial contractility and coronary flow ( Table 1) .
As shown in Table 2 , SAH accumulated dosedependently during hypoxic perfusion (30% O2) when homocysteine was infused at final concentrations of 0.01, 0.05, and 0.2 mM. Rates of SAH formation with homocysteine concentrations of 0.2 and 1.0 mM were not significantly different from each other suggesting enzyme saturation with homocysteine under these conditions. Increasing oxygen demand of spontaneously beating hypoxic hearts (heart rate 206 ± 6 beats/min) by atrial pacing (300 beats/min) enhanced SAH accumulation rate twofold ( Table 2) . Highest rates of SAH accumulation were measured during adenosine infusion at a concentration of 100 yM (homocysteine 1 mM).
The kinetic data of SAH-hydrolase in the isolated heart were derived from the Lineweaver-Burk plot shown in Figure 2 . Since global tissue adenosine does not represent the substrate concentration to which the enzyme is exposed free intracellular adenosine concentration (Table 3) was estimated from adenosine levels measured in the presence of a saturating homocysteine concentration (1 mM) given in Table 2 . Comparison of these estimates showed only slight differences whether Equation 1 or 2 was used for calculation (see "Calculations and Statistics"). Free intracellular adenosine, however, changed to a much greater extent than total tissue adenosine ( Figure 2) .
In an additional experimental series, the P02 of the perfusion medium containing 1 mM homocysteine was systematically varied between 660 ±15 Discussion The present study demonstrates that in the presence of L-homocysteine, increasing adenosine formation by lowering cardiac oxygen supply results in a marked and progressive increase in tissue SAH levels that far exceeds steady-state changes in total tissue adenosine content. This was shown for the isolated perfused guinea pig heart (Figures 1 and 3) and similar results were obtained for the dog heart in situ. 29 Since SAH-hydrolase is a cytosolic enzyme 1217 and L-homocysteine was present at a saturating concentration, the rate of SAH formation in the homocysteine-pretreated heart reflects the concentration of free intracellular adenosine.
Measurement of adenosine in acid tissue extract does not differentiate between protein-bound and free adenosine. There is accumulating evidence that the bulk of acid extractable adenosine is tightly bound to intracellular proteins, presumably SAHhydrolase. 1516 This fraction constitutes a biologically inert pool 25 -26 that does not participate in various metabolic reactions of adenosine (for review, see Ueland 20 ). Because of this high "background" of bound adenosine, changes in the concentration of free intracellular adenosine are difficult to measure by currently used extraction procedures. The present study shows that conversion of free intracellular adenosine to SAH can circumvent this problem. Due to the fact that SAH formation increased at a constant rate (Figure 1) Table 3 ). Rate of SAH accumulation was calculated from data shown in Table 2 
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Values were derived from measurement of total tissue adenosine and coronary venous effluent adenosine concentration using Table 2 when homocysteine was present at a saturating concentration of I mM.
changes in the concentration of free intracellular adenosine are amplified by conversion into SAH.
Quantification of Free Intracellular Adenosine Concentration
Data reported for SAH accumulation are not limited to a qualitative interpretation but permit a more detailed description of free intracellular adenosine levels. Free adenosine during hypoxia (ARJ is the sum of free adenosine under normoxic conditions (ARJ and an additional amount AR, formed during hypoxia:
For changes of substrate concentrations (cytosolic free adenosine) below the K m value of SAHhydrolase (see below), the relation between the rate of SAH accumulation (SAH) and the free intracellular concentration of adenosine can be assumed to be linear. Thus, one can state the following:
Rearrangement of Equations 3 and 4 then gives: (4)
A R c = 7T7 (5) All variables on the righthand side of Equation 5 have been measured or can be directly calculated from measured values (Figures 1 and 3) . They are individually represented together with the calculated value for AR,. in Table 4 . It is evident from this table that even though the data were obtained in experiments in which oxygenation was varied over a wide range, the values calculated for free intracellular adenosine levels of normoxic hearts (AR,.) were remarkably constant between 0.041 and 0.077 nmoles/g. During hypoxia, free intracellular adenosine level (AR,,) increased to values as high as 1.57 nmoles/g. Since the interstitial space of the heart amounts to 20-30% of total tissue volume 28 the intracellular adenosine concentration amounts to 
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7 M during normoxia and increases to 2.0 x 10~6 M during severe hypoxia.
The above calculation of free cytosolic adenosine is based upon the following assumptions:
1) The relation between substrate concentration (adenosine) and reaction velocity (SAH accumulation) is linear. This holds true when substrate concentration is in the range of the K m value or lower. Under in vitro conditions, K m values of SAHhydrolase for adenosine have been reported between 0.4 and 20 /AM. 30 -32 In the present study, we have made an attempt to obtain an estimate for the K m value under in vivo conditions. For this purpose, adenosine levels were enhanced by hypoxia, pacing, or adenosine infusion and corresponding rates of SAH accumulation and global tissue adenosine were measured. After correction for protein-bound and extracellular adenosine, an apparent K m value for adenosine of 17-24 JAM and a V^ value of 2 nmoles/min/mg protein (59 nmoles/min/g wet wt) was determined. As evident from Table 4 , the free cytosolic adenosine concentration determined for the normoxic heart (0.08 fiM) and during graded hypoxic perfusion (0.2-2.0 jiM) was in all cases far below the K m value of the in vivo SAH-hydrolase. 2) Perfusion with a hypoxic medium does not alter the specific activity of cardiac SAH-hydrolase. Support for the validity of this assumption is derived from the observation that the ratio between the rate of SAH accumulation and tissue adenosine level is constant and independent of tissue oxygenation (0.46 + 0.02 and 0.51 ±0.10 1/min for infusion of 100 pM. adenosine under normoxic and hypoxic conditions, respectively; data are taken from Table 2 ). Furthermore, the pH optimum of SAH-hydrolase is rather broad, 29 and in contrast to stop-flow ischemia, pH changes during hypoxic perfusion of the isolated heart are presumably only small.
3) The level of protein-bound adenosine is constant. It has previously been shown that sequestered adenosine is only very slowly released from SAH-hydrolase with a half-life of several hours and is not further metabolized to SAH in the presence of free homocysteine. 23 - 24 In addition, protein-bound adenosine remained constant when different degrees of cell damage caused marked changes in total adenosine. 26 The use of homocysteine to measure free cytosolic adenosine concentration may have decreased myocardial adenosine below its normal level, since homocysteine infusion decreased the release of adenosine by 25% (normoxia) and 60% (hypoxia), respectively. To what degree, however, free intracellular adenosine concentration was decreased is difficult to assess at present. Only when the rate of SAH formation exceeds the flux through the adenosine kinase and the adenosine deaminase pathways can one expect the concentration of adenosine to be considerably lowered.
Adenosine Metabolism
Because of the low K m value (0.2-0.9 fxM) of adenosine kinase 12 -33 and because global tissue adenosine content is approximately 1-2 nmoles/g adenosine kinase has been postulated to operate close to saturation under normoxic conditions. 33 Therefore, a substrate cycle between adenosine and AMP was proposed to explain the greatly augmented formation of adenosine during hypoxia in view of only moderate changes in tissue AMP. 33 - 34 This view has been questioned by Newby, 35 who observed that under in vivo conditions the incorporation of radiolabeled adenosine into intracellular nucleotides is significantly enhanced during hypoxia. 36 The low concentration of free cytosolic adenosine of approximately 0.08 ^M determined in the present study provides additional strong evidence that in the normoxic heart adenosine kinase is operating below its K m . Recent data from our laboratory indicate that enhanced adenosine formation during hypoxia is not only due to increased levels of AMP but also to the activation of 5'-nucleotidase. 37 Similar to adenosine, which is sequestered by SAH-hydrolase, 20 large fractions of tissue ADP and AMP are known to be bound to cytosolic enzymes and contractile proteins." Using the myokinase mass action equation, Bunger and Soboll 38 calculated the free cytosolic concentration of AMP to be 0.1 JAM under control conditions, which is 1,000 times smaller than measured levels of total tissue AMP. During low-flow ischemia and simultaneous £-adrenoceptor stimulation, the free cytosolic AMP concentration increased to values as high as 0.8 fxM. Since the study of Bunger and Soboll was performed in the same animal species and experimental preparation as our study it is interesting to note that during normoxia, this calculated free AMP concentration (0.1 ^M) is in the same range as the free adenosine concentration (0.08 /AM) determined in the present study. During a hypoxic challenge, both AMP and adenosine increased severalfold to values that again were in the same range.
The preferential site of adenosine formation within the heart is presumably intracellular. This hypothesis is supported by the finding that 5'-nucleotidase activity in the cytosolic compartment is sufficiently high to account for the rate of adenosine production during hypoxia 14 and that nucleoside transport inhibitors further increase tissue levels of adenosine during hypoxia but decrease its release into the effluent perfusate. 12 The intracellularly produced adenosine was, therefore, assumed to be released into the interstitial space according to its concentration gradient to finally reach the vascular space where it is washed out with the coronary circulation. At present, there are no data available on the concentration gradient of free adenosine across the cardiomyocyte cell membrane. However, interstitial adenosine concentrations in the isolated nonworking rat heart have been recently reported between 0.04 and 0.09 /xM under control conditions, 39 which is similar to the free cytosolic concentration of adenosine obtained in the present study (approximately 0.08 /iM). On the other hand, the adenosine concentration in the coronary effluent perfusate is only approximately 0.01 fiM under normoxic conditions (95% O2) and increases to 0.15 fiM under hypoxic conditions (30% O2). 40 Thus, there appears to be a large concentration gradient between the interstitial and the vascular adenosine concentration. This is consistent with the hypothesis that the endothelial cells form a highly active metabolic barrier 41 
-
42 not only for intracoronarily applied adenosine but also for adenosine formed by the cardiomyocyte compartment.
Coronary Flow and Adenosine
The hypothesis that adenosine is a major factor in the metabolic control of coronary blood flow has been tested in the past using adenosine-receptor blockers (e.g., theophylline and aminophylline) or infusion of adenosine deaminase, which degrades vasoactive adenosine to vasoinactive inosine (for review, see Feigl 2 ). In a more recent approach to test the adenosine hypothesis, homocysteine has been used by Sadick et al. 43 In this study, it was assumed that homocysteine can critically lower the interstitial concentration of adenosine and therefore should be associated with a decrease in coronary flow. Homocysteine, however, did not significantly influence the reactive hyperemic flow response following coronary occlusion in the open-chest dog heart. Similarly, the present study shows that homocysteine did not alter coronary flow during hypoxia although it significantly decreased adenosine release into the coronary effluent perfusate.
The underlying assumption of the approach of Sadick et al 43 was that homocysteine alters efflux of adenosine by the heart and the interstitial adenosine concentration to the same extent. Recent evidence shows that this may not be a valid assumption. Coronary endothelium is characterized by a highaffinity uptake system for adenosine 42 not shared with vascular smooth muscle cells or cardiomyocytes. 44 - 45 Furthermore, SAH-hydrolase activity of microvascular endothelium was recently shown to be approximately four times higher than the specific activity of this enzyme in cardiomyocytes. 46 It is therefore conceivable that the combined effect of the high-affinity uptake system and rapid intracellular incorporation of adenosine into the endothelial SAH pool may considerably steepen the concentration gradient to the vascular space but leave interstitial adenosine concentration relatively unchanged. Although the SAH-hydrolase activity is higher in the endothelial compartment, overall synthesis of SAH most likely reflects changes in the cardiomyocytes since on a weight basis this cell species comprizes 85% of the left ventricle compared with 3% of the vascular endothelium. 47 It should also be noted that other studies using adenosine deaminase or aminophylline showed an attenuation of the reactive hyperemic flow response (for review, see Feigl 2 ). Again, this casts doubt that homocysteine can be used to test the adenosine hypothesis of coronary flow regulation.
Another possibility to explain a decrease in cardiac adenosine release despite unchanged coronary flow would be that homocysteine increased the sensitivity of coronary receptors toward adenosine. However, the vasoreactivity of the coronary resistance vessels toward exogenously applied adenosine was not altered by homocysteine, making this possibility rather unlikely.
In the present study, a new index for the biologically active fraction of adenosine in the heart was obtained, namely, the concentration of free cytosolic adenosine. A close relation was found between calculated concentrations of free cytosolic adenosine and measured coronary flow during graded hypoxia (Figure 4 ). Threshold increase in coronary flow was associated with a free cytosolic adenosine concentration of 0.08 /AM and maximal coronary dilation was observed when this concentration had increased to 2.0 /xM. An almost identical doseresponse curve is obtained when adenosine is infused intracoronarily. 48 Assuming that adenosine can rapidly diffuse from the intracellular to the interstitial space, this suggests that the rate of cytosolic adenosine formation during hypoxia is quantitatively sufficient to account for most of the observed changes in coronary flow.
